VerbatimParliament, as it happens

Parkinson's Disease: Newcastle-under-Lyme

Asked by Adam JogeeLabourDepartment of Health and Social CareTabled Answered 9 September 2024UIN 3459

The question

To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of procuring Produodopa via the NHS on the treatment of Parkinson's disease in Newcastle-Under Lyme constituency.

Answered by Karin Smyth

The National Institute for Health and Care Excellence (NICE) published guidance recommending foslevodopa–foscarbidopa (Produodopa) for patients with Parkinson’s disease meeting specified clinical criteria, in November 2023. Produodopa is now available to eligible National Health Service patients in England, including in Newcastle-Under Lyme, in line with the NICE’s recommendations.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim